Treated T-cells induce remissions in chemo-refractory B-cell lymphomas The Oncology Report One patient who, despite having undergone 10 prior therapies -- including 3 rituximab-based chemotherapy regimens -- continued to have lymphoma involvement of the liver and other abdominal areas, remains in complete remission 9 months after treatment ... |
